Molecular mechanisms underlying bacterial resistance to ceftazidime/avibactam-Reference-Cited by-同舟云学术

Molecular mechanisms underlying bacterial resistance to ceftazidime/avibactam

Published:2022-07-26 Issue:6 Volume:14 Page:
ISSN:2692-9368
Container-title:WIREs Mechanisms of Disease
language:en
Short-container-title:WIREs Mechanisms of Disease

Author:

Xiong Luying¹,Wang Xueting¹,Wang Yuan¹,Yu Wei¹,Zhou Yanzi¹,Chi Xiaohui¹,Xiao Tingting¹,Xiao Yonghong¹²^ORCID

Affiliation:

1. Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, College of Medicine Zhejiang University Hangzhou China

2. Jinan Microecological Biomedicine Shandong Laboratory Jinan China

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/wsbm.1571

Reference93 articles.

1. High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production inEnterobacteriaceaeBloodstream Infections at a Major Cancer Center: Table 1.

2. Klebsiella pneumoniae carbapenemase (KPC) producer resistant to ceftazidime–avibactam due to a deletion in the blaKPC3 gene

3. Klebsiella pneumoniae Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from β-Lactamase Protein Engineering

4. Current Challenges in Antimicrobial Chemotherapy

5. In vitro activity of AVE1330A, an innovative broad-spectrum non- -lactam -lactamase inhibitor

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism-guided strategies for combating antibiotic resistance;World Journal of Microbiology and Biotechnology;2024-08-10

2. On the assessment of the role of new antibiotics in pharmacotherapy algorithms for complicated intra-abdominal infections (literature review);Journal of Volgograd State Medical University;2024-08-05

3. Dynamic evolution of ceftazidime-avibactam resistance from a single patient through the IncX3_NDM-5 plasmid transfer and blaKPC mutation;International Journal of Antimicrobial Agents;2024-08

4. Synergistic Effect of Ceftazidime-Avibactam with Aztreonam on Carbapenemase-Positive Klebsiella pneumoniae MBL+, NDM+ [Response to Letter];Infection and Drug Resistance;2024-07

5. Ceftazidime/avibactam versus polymyxin B in carbapenem-resistant Klebsiella pneumoniae infections: a propensity score-matched multicenter real-world study;Infection;2024-06-17